Literature DB >> 8253951

Polymorphism in ospC gene of Borrelia burgdorferi and immunoreactivity of OspC protein: implications for taxonomy and for use of OspC protein as a diagnostic antigen.

M Theisen1, B Frederiksen, A M Lebech, J Vuust, K Hansen.   

Abstract

The nucleotide sequences of the ospC gene from five Danish human Borrelia burgdorferi isolates representing all three B. burgdorferi genospecies (B. burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461) and from the American type strain B31 were determined and compared with the published ospC sequence from the German B. burgdorferi isolate PKo (R. Fuchs, S. Jauris, F. Lottspeich, V. Preac-Mursic, B. Wilske, and E. Soutschek, Mol. Microbiol. 6:503-509, 1992). The ospC gene was present in all isolates, regardless of the presence or absence of its product, OspC. The deduced amino acid sequences of OspC from the seven isolates were aligned and revealed pairwise sequence identities ranging from 60.5 to 100%. Differences were scattered throughout the amino acid sequences. A phylogenetic tree was constructed and revealed three distinct phenotypic groups OspCI to OspCIII corresponding to the three delineated genospecies. Immunoblot analysis revealed that the seven OspC proteins tested have both common and specific epitopes. There is significant epitope diversity, since even polyclonal antisera showed serotype-restricted specificity. Therefore, a serodiagnostic assay for Lyme borreliosis utilizing OspC as a test antigen should include all three OspC phenotypes in order to obtain a species-wide sensitivity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253951      PMCID: PMC265938          DOI: 10.1128/jcm.31.10.2570-2576.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

Review 1.  Clinical definitions and differential diagnosis of Lyme arthritis.

Authors:  A C Steere
Journal:  Scand J Infect Dis Suppl       Date:  1991

2.  Antigenic variability of Borrelia burgdorferi.

Authors:  B Wilske; V Preac-Mursic; G Schierz; R Kühbeck; A G Barbour; M Kramer
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

3.  Molecular analysis and expression of a Borrelia burgdorferi gene encoding a 22 kDa protein (pC) in Escherichia coli.

Authors:  R Fuchs; S Jauris; F Lottspeich; V Preac-Mursic; B Wilske; E Soutschek
Journal:  Mol Microbiol       Date:  1992-02       Impact factor: 3.501

Review 4.  Early and late cutaneous manifestations in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme borreliosis).

Authors:  E Asbrink; A Hovmark
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

5.  Comparison of flagellum and sonicate antigens for serological diagnosis of Lyme borreliosis.

Authors:  M Karlsson; G Stiernstedt; M Granström; E Asbrink; B Wretlind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

6.  The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production.

Authors:  K Hansen; A M Lebech
Journal:  Brain       Date:  1992-04       Impact factor: 13.501

7.  Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.

Authors:  G Baranton; D Postic; I Saint Girons; P Boerlin; J C Piffaretti; M Assous; P A Grimont
Journal:  Int J Syst Bacteriol       Date:  1992-07

Review 8.  Molecular biology of antigenic variation in Lyme borreliosis and relapsing fever: a comparative analysis.

Authors:  A G Barbour
Journal:  Scand J Infect Dis Suppl       Date:  1991

9.  Polymerase chain reaction primers and probes derived from flagellin gene sequences for specific detection of the agents of Lyme disease and North American relapsing fever.

Authors:  R N Picken
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

10.  Improved immunoglobulin M serodiagnosis in Lyme borreliosis by using a mu-capture enzyme-linked immunosorbent assay with biotinylated Borrelia burgdorferi flagella.

Authors:  K Hansen; K Pii; A M Lebech
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  66 in total

Review 1.  Diversity of the Lyme Disease Spirochetes and its Influence on Immune Responses to Infection and Vaccination.

Authors:  Jerilyn R Izac; Richard T Marconi
Journal:  Vet Clin North Am Small Anim Pract       Date:  2019-04-06       Impact factor: 2.093

2.  Molecular cloning and characterization of nlpH, encoding a novel, surface-exposed, polymorphic, plasmid-encoded 33-kilodalton lipoprotein of Borrelia afzelii.

Authors:  M Theisen
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

3.  Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development.

Authors:  Eric L Buckles; Christopher G Earnhart; Richard T Marconi
Journal:  Clin Vaccine Immunol       Date:  2006-10

4.  Borrelia burgdorferi ospC heterogeneity among human and murine isolates from a defined region of northern Maryland and southern Pennsylvania: lack of correlation with invasive and noninvasive genotypes.

Authors:  Muneera Y Alghaferi; Jennifer M Anderson; Jinho Park; Paul G Auwaerter; John N Aucott; Douglas E Norris; J Stephen Dumler
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  Characterization of Borrelia lusitaniae isolates collected in Tunisia and Morocco.

Authors:  Hend Younsi; M'Hammed Sarih; Fatima Jouda; Edmond Godfroid; Lise Gern; Ali Bouattour; Guy Baranton; Daniele Postic
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

6.  Plasmid location of Borrelia purine biosynthesis gene homologs.

Authors:  N Margolis; D Hogan; K Tilly; P A Rosa
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

7.  The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface-exposed conserved structural motif.

Authors:  M J Mathiesen; A Holm; M Christiansen; J Blom; K Hansen; S Ostergaard; M Theisen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Expression and gene sequence of outer surface protein C of Borrelia burgdorferi reisolated from chronically infected mice.

Authors:  B Stevenson; L K Bockenstedt; S W Barthold
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany.

Authors:  B Wilske; U Busch; H Eiffert; V Fingerle; H W Pfister; D Rössler; V Preac-Mursic
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

10.  Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato.

Authors:  B Wilske; V Fingerle; V Preac-Mursic; S Jauris-Heipke; A Hofmann; H Loy; H W Pfister; D Rössler; E Soutschek
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.